Downloads
Abstract
Objective: To investigate the concentration of blood calcium, phosphorus and parathyroid hormone in patients with ESRD who were treated by conservative therapy.
Methods: A cross - sectional descriptive study was performed on 50 patients with ESRD who were treated by conservative therapy at Nghe An Friendship General Hospital. Blood calcium, phosphorus and parathyroid hormone levels were calculated and compared with the normal ranges, respectively.
Results: The average blood calcium concentration was 1.94 ± 0.05 mmol/l, of which 78.00% of the patients had hypocalcemia. The average blood phosphorus concentration was 1.84 ± 0.58 mmol/l, of which 52.00% of the patients had hyperphosphatemia. The average blood Ca x P index was 3.52 ± 1.13 mmol2/l2,of which 22.00% had high blood Ca x P index. The average blood PTH concentration was 280.87 ± 222.35 pg/ml, in which the proportion of patients with increased blood PTH concentration was 36.00%. It was found that blood phosphorus concentration, Ca x P index and blood PTH concentration were inversely correlated with age and glomerular filtration rate.
Conclusion: The study shows that in patients with ESRD who were treated by conservative therapy has a high percentage of patients with low concentration of blood calcium, high concentration ofblood phosphorus and high concentration of blood PTH.
References
Evenepoel P, Wolf M. A balanced view of calcium and phosphate homeostasis in chronic kidney
disease. Kidney Int [Internet]. 2013;83(5):789- 91. Available from: http://dx.doi.org/10.1038/ki.
21
Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and
phosphate in chronic kidney disease. Kidney Int. 2011;79(12):1370-8.
Eddington H, Heaf JG. Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients. NDT Plus. 2009;
(4):267-72.
Zhou L, Fu P. The interpretation of KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention and treatment
of chronic kidney disease - mineral and bone disorder (BTM - MBD). Chinese J Evidence - Based Med. 2017;17(8):869-75.
Levin A, Stevens PE. Summary of KDIGO 2012 BTM Guideline: Behind the scenes, need for guidance, and a framework for moving
forward. Kidney Int [Internet]. 2014;85(1):49- 61. Available from: http://dx.doi.org/10.1038/ki. 2013.444
Nguyễn Hoàng Thanh Vân. Nghiên cứu nồng độ Beta Crosslaps, hormon tuyến cận giáp huyết thanh ở bệnh nhân bệnh thận mạn giai đoạn cuối. Trường Đại học Y khoa Huế; 2015.
Nguyễn Vĩnh Hưng. Nghiên cứu biểu hiện lâm sàng và xét nghiệm rối loạn canxi - phospho ở bệnh nhân suy thận mạn tính. Y học thực hành. 2009;7:47-9.
Qunibi WY. Consequences of hyperphosphatemia in patients with end - stage renal disease (ESRD). Kidney Int Suppl. 2004 Sep;(90):S8-12.
Jean G, Souberbielle JC, Chazot C. Vitamin D in chronic kidney disease and dialysis patients. Nutrients. 2017;9(4):1-15.
Benabdellah N, Karimi I, Bentata Y, Yacoubi H, Haddiya I. [Phospho - calcic status in chronic hemodialysis in Oriental Morocco: assessment ofadherence to K/DOQI and KDIGO recommendations]. Pan Afr Med J. 2013;16:23.
Nguyễn Thanh Minh. Nghiên cứu rối loạn xương, khoáng và các yếu tố liên quan trên bệnh nhân bệnh thận mạn giai đoạn 5 lọc máu chu kỳ. Đại học Y dược Huế; 2021.
Nguyễn Thị Kim Thủy. Nồng độ Calci, phospho, PTH huyết thanh và tình trạng loãng xương ở bệnh nhân suy thận mạn lọc máu chu kỳ. Y học thực hành. 2011;771(6):78-80.
| Published | 09-01-2025 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 73 (2021) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.2021.73.9 | |
| Keywords | Từ khóa: Canxi, phospho, bệnh thận mạn giai đoạn cuối. Key words: Calcium, phosphorus, ESRD. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2021 Journal of Clinical Medicine Hue Central Hospital